FDA Approves World’s First Crispr Gene-Editing Drug for Sickle-Cell Disease
www.wsj.com
The U.S. has approved the world’s first medicine employing Crispr technology, a Nobel Prize-winning discovery that promised a powerful new tool to treat disease.

The key thing about this kind of therapy is that it’s not a drug you keep on taking - it’s a one-time thing which permanently cures the disease.

  • silence7@slrpnk.netOPEnglish
    6·
    1 year ago

    The insurer pays for it by not having to cover the expense of treating the disease anymore. It’s an incredibly expensive disease to manage as a chronic condition. People who have sickle cell are going to have to have budgeted money to cough up their yearly deductible in any case. (Skipping out on paying medical bills is also a possibility)

    And yes, I agree that not everybody will get treatment quickly because of the high cost.